BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yamamoto-Furusho JK, Sarmiento-Aguilar A, Toledo-Mauriño JJ, Bozada-Gutiérrez KE, Bosques-Padilla FJ, Martínez-Vázquez MA, Marroquín-Jiménez V, García-Figueroa R, Jaramillo-Buendía C, Miranda-Cordero RM, Valenzuela-Pérez JA, Cortes-Aguilar Y, Jacobo-Karam JS, Bermudez-Villegas EF; EPIMEX Study Group. Incidence and prevalence of inflammatory bowel disease in Mexico from a nationwide cohort study in a period of 15 years (2000-2017). Medicine (Baltimore) 2019;98:e16291. [PMID: 31277162 DOI: 10.1097/MD.0000000000016291] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 6.7] [Reference Citation Analysis]
Number Citing Articles
1 El-Shabrawi MH, Tarek S, Abou-Zekri M, Meshaal S, Enayet A, Mogahed EA. Hepatobiliary manifestations in children with inflammatory bowel disease: A single-center experience in a low/middle income country. World J Gastrointest Pharmacol Ther 2020; 11(3): 48-58 [PMID: 32844043 DOI: 10.4292/wjgpt.v11.i3.48] [Reference Citation Analysis]
2 de-León-Rendón JL, López-Pérez RY, Gracida-Mancilla NI, Jiménez-Bobadilla B, Alarcón-Bernés L, Mendoza-Ramírez S, Villanueva-Herrero JA. The controlling nutritional status score: A promising tool for nutritional screening and predicting severity in ulcerative colitis patients. Rev Gastroenterol Mex (Engl Ed) 2021;86:110-7. [PMID: 33261942 DOI: 10.1016/j.rgmx.2020.05.012] [Reference Citation Analysis]
3 Juliao-baños F, Puentes F, López R, Saffon M, Reyes G, Parra V, Galiano M, Barraza M, Molano J, Álvarez E, Corrales R, Vargas L, Gil F, Álvarez P, Limas L, Prieto R, Yance P, Díaz F, Bareño J, Juliao-baños F, Arrubla M, Camargo J, Puentes F, Arango L, López R, García R, Mendoza B, Saffon MA, Roldan LF, Zuleta J, Reyes G, Parra V, Flórez C, Nuñez E, Galiano MT, Barraza M, Sanchez IC, Molano JL, Lizarazo JI, Cuellar I, Álvarez E, Corrales R, Gil F, Vargas LE, Álvarez P, Limas LM, Prieto R, Ballén H, Delgado L, Yance P, Díaz F. Characterization of inflammatory bowel disease in Colombia: Results of a national register. Revista de Gastroenterología de México (English Edition) 2021;86:153-62. [DOI: 10.1016/j.rgmxen.2020.05.009] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 de-León-Rendón J, López-pérez R, Gracida-mancilla N, Jiménez-bobadilla B, Alarcón-bernés L, Mendoza-ramírez S, Villanueva-herrero J. The controlling nutritional status score: A promising tool for nutritional screening and predicting severity in ulcerative colitis patients. Revista de Gastroenterología de México (English Edition) 2021;86:110-7. [DOI: 10.1016/j.rgmxen.2020.05.007] [Reference Citation Analysis]
5 Iurciuc Tincu CE, Atanase LI, Jérôme C, Sol V, Martin P, Popa M, Ochiuz L. Polysaccharides-Based Complex Particles' Protective Role on the Stability and Bioactivity of Immobilized Curcumin. Int J Mol Sci 2021;22:3075. [PMID: 33802882 DOI: 10.3390/ijms22063075] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
6 Scharrer-cabello S, Baeza-zapata A, Herrera-quiñones G, Luna-limón C, Benavides-salgado D. Stricturing ulcerative colitis: a case of rapid disease progression. Revista de Gastroenterología de México (English Edition) 2020;85:491-3. [DOI: 10.1016/j.rgmxen.2020.10.004] [Reference Citation Analysis]
7 Juliao-Baños F, Puentes F, López R, Saffon MA, Reyes G, Parra V, Galiano MT, Barraza M, Molano J, Álvarez E, Corrales R, Vargas LE, Gil F, Álvarez P, Limas L, Prieto R, Yance P, Díaz F, Bareño J; Grupo del Registro Colombiano de Enfermedad Inflamatoria Intestinal., Grupo Registro Colombiano de Enfermedad Inflamatoria Intestinal. Characterization of inflammatory bowel disease in Colombia: Results of a national register. Rev Gastroenterol Mex (Engl Ed) 2021;86:153-62. [PMID: 32723624 DOI: 10.1016/j.rgmx.2020.05.005] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Sarmiento-Aguilar A, Ríos-Blancas MJ, Yamamoto-Furusho JK. Mortality and Hospitalizations in Mexican Patients with Inflammatory Bowel Disease: Results from a Nationwide Health Registry. Can J Gastroenterol Hepatol 2020;2020:8825330. [PMID: 32832489 DOI: 10.1155/2020/8825330] [Reference Citation Analysis]
9 Yamamoto-Furusho JK, Parra-Holguín NN, Juliao-Baños F, Puentes F, López R, Bosques-Padilla F, Torres EA, Nieves-Jimenéz H, Veitia-Velásquez GR, Jara-Alba ML, Bautista S, Piñol-Jimenez FN, Salgado-Rosado P, Villa-Ovalles KC, Abreu-Martinez YA, Borges Z, Davila-Bedoya S, Otoya-Moreno G, Iadé-Vergara B; EPILATAM study group. Clinical differentiation of inflammatory bowel disease (IBD) in Latin America and the Caribbean. Medicine (Baltimore) 2022;101:e28624. [PMID: 35060539 DOI: 10.1097/MD.0000000000028624] [Reference Citation Analysis]
10 Teng S, Hao J, Bi H, Li C, Zhang Y, Zhang Y, Han W, Wang D. The Protection of Crocin Against Ulcerative Colitis and Colorectal Cancer via Suppression of NF-κB-Mediated Inflammation. Front Pharmacol 2021;12:639458. [PMID: 33841156 DOI: 10.3389/fphar.2021.639458] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Yamamoto-Furusho JK, Parra-Holguín NN. Real-world experience with MMX mesalazine use in Mexican patients with ulcerative colitis at two tertiary care centers. Rev Gastroenterol Mex (Engl Ed) 2021:S2255-534X(21)00060-8. [PMID: 34794923 DOI: 10.1016/j.rgmxen.2021.06.002] [Reference Citation Analysis]
12 Liang L, Lin R, Xie Y, Lin H, Shao F, Rui W, Chen H. The Role of Cyclophilins in Inflammatory Bowel Disease and Colorectal Cancer. Int J Biol Sci 2021;17:2548-60. [PMID: 34326693 DOI: 10.7150/ijbs.58671] [Reference Citation Analysis]
13 Kotze PG, Steinwurz F, Francisconi C, Zaltman C, Pinheiro M, Salese L, Ponce de Leon D. Review of the epidemiology and burden of ulcerative colitis in Latin America. Therap Adv Gastroenterol 2020;13:1756284820931739. [PMID: 32695230 DOI: 10.1177/1756284820931739] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]